Search Results 101-110 of 11549 for Biliary colic
... biliary cholangitis (PBC) and an inadequate response to or intolerance to ursodeoxycholic acid (UDCA). Participation eligibility. Participant eligibility ...
The objectives of this study are to establish and perpetuate human biliary cell-derived organoids, to assess genetic and signaling pathway alterations in ...
Research. Mayo Clinic has been conducting research on primary biliary cholangitis for more than 50 years. Many treatments for the disease have been studied ...
Participation eligibility · Males or non-pregnant females presenting with cholecystitis, biliary colic or gallstone pancreatitis. · Age 18-95. · Participants must ...
Primary biliary cholangitis is a type of liver disease that damages the bile ducts. Early recognition and treatment may help prevent complications.
About this study. To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis.
Learn about symptoms, risk factors, diagnosis and treatment, including transplant, for this rare cancer that affects the bile ducts of older adults.
Alcoholic liver disease · Autoimmune hepatitis · Benign and malignant liver tumors · Budd-Chiari syndrome · Cholangiocarcinoma (bile duct cancer) · Drug-induced ...
In the following model, short-term survival probability of a patient with primary biliary cholangitis is estimated based on repeated observation.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.